検索結果

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

uate and supply information relating to the quality, efficacy and safety of pharmaceuticals that is available in Japan and other countries as backed by science, and shall do so similarly with post-mar...

Product Development Policy | Research & Development | SENJU Pharmaceutica

it is known as the most common hereditary corneal diseasesup#5,6. Currently, no therapeutic drug is available, and corneal transplantation is performed in patients with severe disease progression. We ...

questionnaire that measures the severity of dry eye symptoms and their impact on daily activities, available for evaluating several aspect of Quality of life including mental health3) 1)：“Dry Eye Dia...

estionnaire that measures the severity of dry eye symptoms and their impact on daily activities, is available for evaluating several aspect of Quality of life including mental health3) 1)：“Dry Eye Dia...

graphic atrophy in Asia. Graefes Arch Clin Exp Ophthalmol 263, 2081–2099 (2025). 3 WHO. Japan Data. Available at: https://data.who.int/countries/392. Date accessed: September 2025 4 Keenan TDL, Cukras...